[1] 张锦海, 陈幸华. 血液肿瘤多药耐药的研究进展. 中国实验血液学杂志2005(6). doi:10.3969/j.issn.1009-2137.2005.06.052
[2] ABD EL-GHAFFAR H A, ALADLE D A, FARAHAT S E. P-glycoprotein (P-170) expression in acute leukemias. 2006(1). doi:10.1080/10245330400026204
[3] GALIMBERTI S, GUERRINI F, CARULLI G. Significant co-expression of WT1 and MDR1 genes in acute myeloid leukemiapatients at diagnosis. 2004(1). doi:10.1046/j.0902-4441.2003.00185.x
[4] BENDERRA Z, FAUSSAT A M, SAYADA L. Boast cancer resistance protein and P-glycoprotein in 149 adult acute myeloid leukemias. 2004(23). doi:10.1158/1078-0432.CCR-04-0795
[5] BENDERRA Z, FAUSSAT A M, SAYADA L. MRP3,BCRP,and P-glycoprotein activities are prognostic factors in adult acute myeloid leukemia. 2005(21). doi:10.1158/1078-0432.CCR-04-1895
[6] HEE J H, CHAN-JEOUNG P, SEONGSOO J. Prognostic significance of multidrug resistance gene 1 (MDR1),multidrug resistance-related protein (MRP) and lung resistance protein (LRP) mRNA expression in acute leukemia. 2006. doi:10.3346/jkms.2006.21.2.253
[7] SUAREZ L, VIDRIALES M B, GARCIA-LARANA J. CD34+ cells from acute myeloid leukemia,myelodysplastic syndromes,and normal bone marrow display different apoptosis and drug resistance-associated phenotypes. 2004(22). doi:10.1158/1078-0432.CCR-04-0598
[8] STAM R W, van den HEUVEL-EIBRINK M M. Multidrug resistance genes in infant acute lymphoblastic leukemia:Ara-C is not a substrate for the breast cancer resistance protein. 2004(1). doi:10.1038/sj.leu.2403168
[9] PLASSCHAERT S L, de BONT E S, BOEZEN M. Expression of multidrug resistance-associated proteins predicts prognosis in childhood and adult acute lymphoblastic leukemia. 2005(24). doi:10.1158/1078-0432.CCR-05-1096
[10] STEINBACH D, WITTIG S, CARIO G. The multidrug resistance associated protein 3 (MRP3) is associated with a poor outcome in childhood ALL and may account for the worse prognosis in male patients and T-cell immunophenotype, 2003(13)
[11] VALERA E T, SCRIDELI C A, QUEIROZ R G. Multiple drug resistance protein (MDR-1),multidrug resistance-related protein (MRP) and lung resistance protein (LRP) gene expression in childhood acute lymphoblastic leukemia, 2004(4)
[12] GURBUXANI S, SINGH A L, RAINA V. Significance of MDR1,MRP1,GSTpi and GSTmu mRNA expressionin acute lymphoblastic leukemia in Indian patients. 2001(1). doi:10.1016/S0304-3835(0)00684-4
[13] SWERTS K, de MOERLOOSE B, DHOOGE C. Prognostic significance of multidrug resistance-related proteins in childhood acute lymphoblastic leukaemia. 2006(3). doi:10.1016/j.ejca.2005.09.017
[14] SCHAICH M, SOUCEK S, THIEDE C. MDR1 and MRP1 gene expression are independent predictors for treatment outcome in adult acute myeloid leukaemia. 2005(3). doi:10.1111/j.1365-2141.2004.05319.x
[15] HUH H J, PARK C J, JANG S. Prognostic significance of multidrug resistance gene 1 (MDR1),multidrug resistance-related protein (MRP) and lung resistance protein (LRP) mRNA expression in acute leukemia. 2006(2). doi:10.3346/jkms.2006.21.2.253
[16] 于萍, 侯柯佐, 郝杰. 急性白血病MRP1与LRP的表达及临床意义. 中国医科大学学报2004(1). doi:10.3969/j.issn.0258-4646.2004.01.022
[17] KURATA M, HASEGAWA M, NAKAGAWA Y. Expression dynamics of drug resistance genes,multidrug resistance 1 (MDR1) and lung resistance protein (LRP) during the evolution of overt leukemia in myelodysplastic syndromes. 2006(3). doi:10.1016/j.yexmp.2006.01.004
[18] GALIMBERTI S, CERVETTI G, GUERRINI F. Quantitative molecular monitoring of BCR-ABL and MDR1 transcripts in patients with chronic myeloid leukemia during Imatinib treatment. 2005(1). doi:10.1016/j.cancergencyto.2005.01.015 |
